Cambrex Corp (NYSE:CBM)
| CAPS Rating |
|
|---|---|
| Open | $6.76 |
| Previous Close | $6.84 |
| Daily Range | $6.74 - $7.10 |
| 52-Week Range | $3.87 - $8.44 |
| Market Cap | $208.38M |
| P/E Ratio | 14.60 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 316,375 |
| Average Daily Volume | 0 |
CBM
VS S&P 500 (SPY)
How do you think CBM will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
CBM Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
CBM News and Commentary
- Why Cambrex May Be About to Take Off – The Motley Fool
- Cambrex Earnings Preview – The Motley Fool
- Cambrex Earnings Preview – The Motley Fool
- 12 Small-Cap Biotech Stocks Being Snapped Up by Mutual Fund Investors – The Motley Fool
- The Earnings Season Top 50 – SeekingAlpha
- 5 Deathbed Stocks – The Motley Fool
- Monday's Worst Stocks in the World – The Motley Fool
- Monday's Biggest Stock Stars – The Motley Fool
- Cambrex in a Crunch – The Motley Fool
- Biotech's Global Agenda – The Motley Fool
- Cambrex's Dose of Reality – The Motley Fool
Related News and Articles
- Illuminating the Way Forward for Genomics – The Motley Fool
- Life Technologies' Sequence of Success – The Motley Fool
- Has Sequenom Become the Perfect Stock? – The Motley Fool
- Hang Tight: This Bid Will Increase – The Motley Fool
- Amass a Fortune With These Stocks – The Motley Fool
- Amass a Fortune With These Stocks – The Motley Fool
- The Promise and Peril of the Mass-Market Genome – The Motley Fool
RSS Headlines
Fool UK
